In addition, THL dose-dependently inhibited the expression of important stemness genes such as the putative hepatoma stem cell marker CD133 [19], as well as the Hedgehog signaling pathways components SMO and Gli [21]. The gene discussed is GLI1; the disease is hepatocellular carcinoma.